Hologic raises annual profit forecast on diagnostic and surgical demand
Hologic raised its profit forecast due to strong demand for diagnostics and surgical products.
View signal analysisCompany intelligence
HOLX
Hologic, Inc. · NASDAQ · Healthcare
Price$76.01+0.00% · +$0.00
Market cap16.97BEquity value
P / E31.5Trailing ratio
Volume101.96MLatest session
Market data
TradingViewHOLX price chart
Related signals
1 min delayedLatest HOLX price-moving signals
Browse public HOLX signals with their source context and measured market impact. Open any signal for its permanent analysis page.
Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?
TPG and Blackstone bid over $16 billion for Hologic Inc. Hologic rejected the nonbinding offer but negotiations may resume. Proposed shares priced at $70 to $72, above closing price of $54.28. Hologic's stock dropped 24% this year due to tariffs and demand issues. Company lowered earnings guidance amid geopolitical challenges.
View signal analysisMedical equipment maker Hologic lowers annual profit forecast on tariff uncertainty
Hologic lowered its fiscal 2025 profit forecast due to tariff uncertainties. The announcement caused a 3% drop in Hologic's shares.
View signal analysisHologic cuts annual revenue forecast on weak demand for breast health products
Hologic cuts fiscal 2025 revenue forecast due to declining breast health product sales. Shares dropped 5% post-announcement, indicating negative market reaction.
View signal analysisHealth Care Roundup: Market Talk - WSJ
Hologic acquires Gynesonics for $350 million to expand gynecological solutions. Acquisition enhances Hologic's minimally invasive surgical tool offerings for OB/GYNs. Hologic shares rose 1.5% to $81.03 following the acquisition news.
View signal analysisHologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Hologic acquires Gynesonics for $350 million to enhance women's health solutions. Gynesonics’ Sonata System offers incisionless treatment for uterine fibroids. Analysts expect Hologic to report $1.01 EPS with $977.05 million revenue. Synergy with existing products could enhance Hologic’s offering in women's health. Growth is expected despite cautious stance due to increased net interest expenses.
View signal analysisResearch